172 related articles for article (PubMed ID: 10858286)
21. Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1.
Shivji MK; Ferrari E; Ball K; Hübscher U; Wood RD
Oncogene; 1998 Dec; 17(22):2827-38. PubMed ID: 9879989
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage.
Ando T; Kawabe T; Ohara H; Ducommun B; Itoh M; Okamoto T
J Biol Chem; 2001 Nov; 276(46):42971-7. PubMed ID: 11559705
[TBL] [Abstract][Full Text] [Related]
23. Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonance.
Knibiehler M; Goubin F; Escalas N; Jónsson ZO; Mazarguil H; Hübscher U; Ducommun B
FEBS Lett; 1996 Aug; 391(1-2):66-70. PubMed ID: 8706932
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein.
Mattock H; Lane DP; Warbrick E
Exp Cell Res; 2001 May; 265(2):234-41. PubMed ID: 11302688
[TBL] [Abstract][Full Text] [Related]
25. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
[TBL] [Abstract][Full Text] [Related]
26. Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.
Wang F; Yoshida I; Takamatsu M; Ishido S; Fujita T; Oka K; Hotta H
Biochem Biophys Res Commun; 2000 Jul; 273(2):479-84. PubMed ID: 10873631
[TBL] [Abstract][Full Text] [Related]
27. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
Luo Y; Hurwitz J; Massagué J
Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
[TBL] [Abstract][Full Text] [Related]
28. Human and plant proliferating-cell nuclear antigen have a highly conserved binding site for the p53-inducible gene product p21WAF1.
Ball KL; Lane DP
Eur J Biochem; 1996 May; 237(3):854-61. PubMed ID: 8647134
[TBL] [Abstract][Full Text] [Related]
29. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
Cayrol C; Knibiehler M; Ducommun B
Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
[TBL] [Abstract][Full Text] [Related]
30. Proliferating cell nuclear antigen (PCNA) interactions in solution studied by NMR.
De Biasio A; Campos-Olivas R; Sánchez R; López-Alonso JP; Pantoja-Uceda D; Merino N; Villate M; Martin-Garcia JM; Castillo F; Luque I; Blanco FJ
PLoS One; 2012; 7(11):e48390. PubMed ID: 23139781
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1.
Mitsui K; Matsumoto A; Ohtsuka S; Ohtsubo M; Yoshimura A
Biochem Biophys Res Commun; 1999 Oct; 264(2):457-64. PubMed ID: 10529385
[TBL] [Abstract][Full Text] [Related]
32. The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition.
Esteve V; Canela N; Rodriguez-Vilarrupla A; Aligué R; Agell N; Mingarro I; Bachs O; Pérez-Payá E
Chembiochem; 2003 Sep; 4(9):863-9. PubMed ID: 12964161
[TBL] [Abstract][Full Text] [Related]
33. Utility of peptide-protein affinity complexes in proteomics: identification of interaction partners of a tumor suppressor peptide.
Gururaja TL; Li W; Payan DG; Anderson DC
J Pept Res; 2003 Apr; 61(4):163-76. PubMed ID: 12605602
[TBL] [Abstract][Full Text] [Related]
34. Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen.
Jónsson ZO; Hindges R; Hübscher U
EMBO J; 1998 Apr; 17(8):2412-25. PubMed ID: 9545252
[TBL] [Abstract][Full Text] [Related]
35. PCNA binding through a conserved motif.
Warbrick E
Bioessays; 1998 Mar; 20(3):195-9. PubMed ID: 9631646
[TBL] [Abstract][Full Text] [Related]
36. Increased proliferative activity caused by loss of p21(WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinoma.
Noda H; Maehara Y; Irie K; Kakeji Y; Yonemura T; Sugimachi K
Cancer; 2002 Apr; 94(7):2107-12. PubMed ID: 11932915
[TBL] [Abstract][Full Text] [Related]
37. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
[TBL] [Abstract][Full Text] [Related]
38. Identification of a functional domain in a GADD45-mediated G2/M checkpoint.
Yang Q; Manicone A; Coursen JD; Linke SP; Nagashima M; Forgues M; Wang XW
J Biol Chem; 2000 Nov; 275(47):36892-8. PubMed ID: 10973963
[TBL] [Abstract][Full Text] [Related]
39. p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues.
Yu P; Huang B; Shen M; Lau C; Chan E; Michel J; Xiong Y; Payan DG; Luo Y
Oncogene; 2001 Jan; 20(4):484-9. PubMed ID: 11313979
[TBL] [Abstract][Full Text] [Related]
40. DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation.
Dong C; Lyu SC; Krensky AM; Clayberger C
J Immunol; 2003 Nov; 171(10):5064-70. PubMed ID: 14607903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
